HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Rose Sheet

Executive Summary

Coty Acquires OPI

You may also be interested in...



In Brief

L’Oreal considers travel retail a “sixth continent” in terms of consumer reach and creates a new division to better serve the segment; firm separately announces it will shutter its mail-order division. More news in brief.

Poised For IPO, Coty Bills Itself As Emerging “Multi-Segment” Beauty Firm

After failing to acquire Avon and calling off a planned IPO in 2012, Coty once again prepares to go public, targeting $700 million in funding.

From Spazzstick To Chicken Poop: Lip Balm Makers Continue To Stretch Market

Pickle-In-A-Pouch marketer Van Holten’s launches Big Papa Dill Pickle Lip Balm, making its personal-care debut in a category where consumers can find every flavor from corndog and bacon to Chicken Poop.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017348

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel